UE2343
Product Specifications
UNSPSC Description
UE2343 is an orally available, brain-penetrant 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor. UE2343 is being investigated for the treatment of Alzheimer's disease[1].
Target Antigen
11β-HSD
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/ue2343.html
Smiles
O=C(C1=CSC(C2=CNN=C2)=C1)N3[C@]4([H])C[C@@](C[C@@]3([H])CC4)(C5=NC=CC=N5)O
Molecular Weight
381.45
References & Citations
[1]Webster S P, et al. Selection and early clinical evaluation of the brain‐penetrant 11β‐hydroxysteroid dehydrogenase type 1 (11β‐HSD1) inhibitor UE2343 (Xanamem™)[J]. British Journal of Pharmacology, 2017, 174(5): 396-408.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-117609/UE2343-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-117609/
Clinical Information
Phase 1
CAS Number
1346013-80-6
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7064959 Inquire
Recombinant Staphylococcus aureus UPF0060 membrane protein NWMN_2240 (NWMN_2240), partial
Ask
View Details